£14k
No changevs Sept 2024Active08046959Private limited companyCambridge
TRANSTHERA LTD
B68/100Owned by Andreas Gerhard Schatzlein and Professor Ijeoma Florence Uchegbu
01
Summary
TRANSTHERA LTD is an active private limited company (company number 08046959) incorporated on 26 April 2012, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 September 2025, showing net assets of £14k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Key dates
- Incorporated
- 26 April 201214 yrs ago
- Next accounts due
- 30 June 2027in 251 days
- Confirmation statement due
- 10 May 2027in 200 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
04
Financials
Not reported
Not disclosed
0
vs Sept 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £14k | — | — | £0 | — | — | 0 |
| 30 September 2024 | £14k | — | — | £0 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
05
Firmoscan score
68 / 100 · grade B
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £13,822 at 2025-09-30 |
| +8 | EstablishedIncorporated 2012-04-26 (14 years) |
| 68 | Score, grade B |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Dr Andreas Gerhard Schatzlein
- owns 25–50% of shares
- Professor Ijeoma Florence Uchegbu
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Next accounts duein 251 days
- Confirmation statement duein 200 days
- Accounts period endNet assets £14k · micro accounts
- Accounts period endNet assets £14k · micro accounts
- Incorporated
08
Similar companies in Cambridge
- CYPRALIS LIMITEDCambridge · inc. Apr 2012
- BIOMODAL LIMITEDSaffron Walden · inc. Mar 2012
- CAMBRIDGE ONCOMETRIX LIMITEDHaverhill · inc. Jun 2012
- NERRE THERAPEUTICS LTDCambridge · inc. Jan 2012
- CHEMICAL INTELLIGENCE LIMITEDCambridge · inc. Aug 2012
- REVOLO BIOTHERAPEUTICS LIMITEDCambridge · inc. Oct 2011
All companies incorporated on 26 April 2012 · in Apr 2012.
09
Reminders for TRANSTHERA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.